Company profile

Minoryx Therapeutics

Developing drugs for orphan CNS diseases

Industry
Biotechnology
Employees
33
Headquarters
Mataró, Barcelona
Founded
2011
LinkedIn followers
8,890
Office locations
2

Minoryx Therapeutics company summary

Minoryx Therapeutics is a company in the Biotechnology industry, headquartered in Mataró, Barcelona, founded in 2011. On LinkedIn the company has around 33 employees and 8,890 followers. The company lists 2 office locations. Its listed specialties include Rare diseases, Neurometabolic diseases, X-linked Adrenoleukodystrophy, Friedreich's Ataxia, Orphan CNS.

What technology does Minoryx Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Minoryx Therapeutics

Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx was founded in 2011, is headquartered in Spain with Belgian facilities and has so far raised more than €120 million

Specialties

Rare diseasesNeurometabolic diseasesX-linked AdrenoleukodystrophyFriedreich's AtaxiaOrphan CNS

Where is Minoryx Therapeutics located?

Minoryx Therapeutics lists 2 office locations.

Mataró, Barcelona, ESHQ
Av. Ernest Lluch 32, TCM2
Gosselies, Charleroi, BE
Rue Auguste Piccard 48

Compare companies similar to Minoryx Therapeutics

More companies in Biotechnology.

CompanyIndustryEmployeesFoundedHeadquarters
Minoryx Therapeutics
minoryx.com
Biotechnology332011Mataró, Barcelona
Regeneron
regeneron.com
Biotechnology17,234-Tarrytown, New York
Bharat Biotech
bharatbiotech.com
Biotechnology2,0351996Hyderabad, Telangana
Biotechnology1,0232008Pune, Maharashtra
Biotechnology393-Bethesda, MD
Biotechnology2,6502004Chennai, India
Biotechnology6922001Cambé, PR
Organica Biotech
organicabiotech.com
Biotechnology1462000Mumbai, Maharashtra
Biotechnology2172017South San Francisco, California
Biotechnology2271971Lagoa Santa, Minas Gerais
Biotechnology2432015London, United Kingdom

Frequently asked questions about Minoryx Therapeutics

What does Minoryx Therapeutics do?

Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company’s lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx was founded in 2011, is headquartered in Spain with Belgian facilities and has so far raised more than €120 million

How many employees does Minoryx Therapeutics have?

Minoryx Therapeutics has around 33 employees on LinkedIn.

Where is Minoryx Therapeutics headquartered?

Minoryx Therapeutics is headquartered in Mataró, Barcelona.

Where does Minoryx Therapeutics have offices?

Minoryx Therapeutics lists 2 office locations, including Mataró, Barcelona, ES; Gosselies, Charleroi, BE.

When was Minoryx Therapeutics founded?

Minoryx Therapeutics was founded in 2011.

Build a lead list from companies like Minoryx Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.